Invention Grant
US09073873B2 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
有权
用于治疗氧化应激疾病的2-杂环氨基烷基 - （对醌）衍生物
- Patent Title: 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
- Patent Title (中): 用于治疗氧化应激疾病的2-杂环氨基烷基 - （对醌）衍生物
-
Application No.: US14223932Application Date: 2014-03-24
-
Publication No.: US09073873B2Publication Date: 2015-07-07
- Inventor: Andrew W. Hinman , Orion D. Jankowski , Kieron E. Wesson
- Applicant: Edison Pharmaceuticals, Inc.
- Applicant Address: US CA Mountain View
- Assignee: Edison Pharmaceuticals, Inc.
- Current Assignee: Edison Pharmaceuticals, Inc.
- Current Assignee Address: US CA Mountain View
- Agency: Squire Patton Boggs (US) LLP
- Main IPC: C07C50/04
- IPC: C07C50/04 ; C07D239/50 ; A61K31/22 ; A61K31/505 ; A61P3/10 ; A61P25/16 ; A61P25/14 ; A61P25/00 ; C07D239/42 ; C07D213/74
Abstract:
Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the methods of the invention, such as 2-heterocyclylaminoalkyl-(p-quinone) derivatives.
Public/Granted literature
- US20140323509A1 2-HETEROCYCLYLAMINOALKYL-(P-QUINONE) DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES Public/Granted day:2014-10-30
Information query
